Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bovine coronavirus spike protein (S protein) is the primary surface antigen of Bovine coronavirus (BCoV), a betacoronavirus that causes significant enteric and respiratory diseases in cattle [3, 13]. It is a large, trimeric class I fusion glycoprotein that forms the characteristic spikes on the viral envelope [3, 10]. The protein is composed of two subunits, S1 and S2, which are responsible for host cell attachment and membrane fusion, respectively [11, 12]. Specifically, the S1 subunit binds to 9-O-acetylated sialic acid receptors on the surface of respiratory and enteric epithelial cells [1, 14]. This binding event triggers conformational changes in the S2 subunit that lead to the fusion of the viral and host membranes, allowing the viral genome to enter the cell [3, 15]. As the major target for neutralizing antibodies, the spike protein is the central immunogen in commercial vaccines used to prevent neonatal calf diarrhea and winter dysentery [12, 14]. It also plays a critical role in the bovine respiratory disease complex (BRDC) by facilitating infection of the upper and lower respiratory tracts [11, 12]. Diagnostic assays, such as ELISA and immunofluorescence, frequently target the spike protein to detect BCoV infection in clinical samples [9, 13]. The protein's high degree of glycosylation and potential for antigenic drift present challenges for long-term vaccine efficacy and therapeutic development [11, 12]. Understanding the structural and functional properties of the BCoV spike protein is essential for developing next-generation antivirals and more effective immunization strategies [10, 15].
Neutralization of viral entry by blocking receptor binding or inhibiting membrane fusion.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bovine coronavirus spike protein (S protein) (BCoV S protein).